Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Emily S. Tonorezos"'
Publikováno v:
Cardio-Oncology, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background Anthracycline chemotherapy and thoracic radiation therapy (RT) are known causes of cardiomyopathy among cancer survivors, however, management guidelines for this population are lacking. In this study we describe our single institu
Externí odkaz:
https://doaj.org/article/d4d6af91b82b4f88b9c43384df03c8ce
Autor:
Eric J. Chow, Yan Chen, Gregory T. Armstrong, Laura‐Mae Baldwin, Casey R. Cai, Todd M. Gibson, Melissa M. Hudson, Aaron McDonald, Paul C. Nathan, Jeffrey E. Olgin, Karen L. Syrjala, Emily S. Tonorezos, Kevin C. Oeffinger, Yutaka Yasui
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background Determine the prevalence and predictors associated with underdiagnosis and undertreatment of modifiable cardiovascular disease (CVD) risk factors (hypertension, dyslipidemia, glucose intolerance/diabetes) among adult survivors of childhood
Externí odkaz:
https://doaj.org/article/dfa0d7dd1b06429b973342235636c911
Publikováno v:
Cardio-Oncology, Vol 8, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/4025341faffc41dda774c656d0054648
Publikováno v:
Cancer Medicine, Vol 7, Iss 11, Pp 5812-5819 (2018)
Abstract Background Supportive care is a critical component of the treatment of cancer patients that is underutilized; patient lack of information about these services is an important barrier. Mobile technologies may be useful tools for delivering in
Externí odkaz:
https://doaj.org/article/1250906c2cd1484fb7c807e6907117e9
Autor:
Emily S. Tonorezos, Tara O. Henderson
Publikováno v:
Children, Vol 1, Iss 2, Pp 227-240 (2014)
The Long-Term Follow-Up Guidelines for survivors of childhood, adolescent, and young adult cancers are evidence- and consensus-based guidelines that have been developed and published by the Children’s Oncology Group (COG) Late Effects Committee, Nu
Externí odkaz:
https://doaj.org/article/5d3cb87fec4446d3abaeffe8dcc15190
Autor:
Jyoti Malhotra, Emily S. Tonorezos, Marina Rozenberg, Gloria L. Vega, Charles A. Sklar, Joanne Chou, Chaya S. Moskowitz, Debra A. Eshelman-Kent, Peter Janiszewski, Robert Ross, Kevin C. Oeffinger
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 12, Pp 2747-2754 (2012)
Survivors of childhood acute lymphoblastic leukemia (ALL) have an increased risk of cardiovascular disease. Small density lipoproteins are atherogenic but have not been studied in this population. We conducted a cross-sectional analysis of 110 ALL su
Externí odkaz:
https://doaj.org/article/d70357807326402889974bf064f02173
Autor:
Amber Khan, Amy Budnick, Dana Barnea, Darren R. Feldman, Kevin C. Oeffinger, Emily S. Tonorezos
Publikováno v:
Children, Vol 5, Iss 5, p 59 (2018)
The ototoxic effects of radiotherapy have been poorly characterized. We examined adult survivors of childhood cancer who were treated with radiotherapy, which included the head, before the age of 22 years and between 1952 and 2016. Those who received
Externí odkaz:
https://doaj.org/article/c30f313342b0430fbd17d95d9cf6ea57
Autor:
Danielle Novetsky Friedman, Pamela J. Goodman, Wendy M. Leisenring, Lisa R. Diller, Susan L. Cohn, Rebecca M. Howell, Susan A. Smith, Emily S. Tonorezos, Suzanne L. Wolden, Joseph P. Neglia, Kirsten K. Ness, Todd M. Gibson, Paul C. Nathan, Brent R. Weil, Leslie L. Robison, Kevin C. Oeffinger, Gregory T. Armstrong, Charles A. Sklar, Tara O. Henderson
Publikováno v:
Journal of Clinical Oncology. 41:1565-1576
PURPOSE To describe the risk of late mortality, subsequent malignant neoplasms (SMNs), and chronic health conditions (CHCs) in survivors of neuroblastoma diagnosed in infancy by treatment era and exposures. METHODS Among 5-year survivors of neuroblas
Autor:
Emily S Tonorezos, Valérie Marcil
Publikováno v:
The Lancet. 401:1403-1405
Autor:
Dana Barnea, Emily S. Tonorezos, Amber Khan, Joanne F. Chou, Chaya S. Moskowitz, Rana Kaplan, Suzanne L. Wolden, Yolanda Bryce, Kevin C. Oeffinger
Publikováno v:
Journal of Cancer Survivorship.